Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Net Margin (2023 - 2025)

Historic Net Margin for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to 2623.53%.

  • CG Oncology's Net Margin rose 448299600.0% to 2623.53% in Q3 2025 from the same period last year, while for Sep 2025 it was 6963.43%, marking a year-over-year increase of 45466600.0%. This contributed to the annual value of 7729.5% for FY2024, which is 255048100.0% up from last year.
  • CG Oncology's Net Margin amounted to 2623.53% in Q3 2025, which was up 448299600.0% from 66263.46% recorded in Q1 2025.
  • In the past 5 years, CG Oncology's Net Margin registered a high of 2623.53% during Q3 2025, and its lowest value of 2249000.0% during Q4 2023.
  • In the last 3 years, CG Oncology's Net Margin had a median value of 17028.83% in 2024 and averaged 288170.62%.
  • Its Net Margin has fluctuated over the past 5 years, first soared by 2000000000bps in 2024, then plummeted by -630627100bps in 2025.
  • CG Oncology's Net Margin (Quarter) stood at 2249000.0% in 2023, then soared by 100bps to 6973.25% in 2024, then surged by 62bps to 2623.53% in 2025.
  • Its Net Margin was 2623.53% in Q3 2025, compared to 66263.46% in Q1 2025 and 6973.25% in Q4 2024.